Filter News
News Topics
- (-) Grid (3)
- (-) Isotopes (3)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (4)
- Artificial Intelligence (17)
- Big Data (6)
- Bioenergy (14)
- Biology (18)
- Biomedical (5)
- Biotechnology (12)
- Buildings (1)
- Chemical Sciences (5)
- Clean Water (1)
- Composites (2)
- Computer Science (11)
- Environment (4)
- Exascale Computing (10)
- Fossil Energy (1)
- Frontier (7)
- Fusion (6)
- High-Performance Computing (14)
- ITER (1)
- Machine Learning (6)
- Materials (3)
- Materials Science (6)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (4)
- National Security (5)
- Neutron Science (8)
- Nuclear Energy (8)
- Partnerships (7)
- Physics (3)
- Polymers (2)
- Quantum Computing (9)
- Quantum Science (14)
- Security (1)
- Simulation (7)
- Space Exploration (1)
- Summit (4)
- Transportation (3)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 5 of 5 Results
Researchers at 91°µÍø have developed a modeling method that uses machine learning to accurately simulate electric grid behavior while protecting proprietary equipment details. The approach overcomes a key barrier to accurate grid modeling, helping utilities plan for future demand and prevent blackouts.
Scientists at ORNL have developed a method that can track chemical changes in molten salt in real time — helping to pave the way for the deployment of molten salt reactors for energy production.

During his first visit to 91°µÍø, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.â€

Researchers at 91°µÍø have developed a new automated testing capability for semiconductor devices, which is newly available to researchers and industry partners in the Grid Research Integration and Deployment Center.

Ryan Culler is the program manager at 91°µÍø, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.